Literature DB >> 19861984

Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated.

D Yokoe1, C Casper, E Dubberke, G Lee, P Muñoz, T Palmore, K Sepkowitz, J-A H Young, J P Donnelly.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19861984     DOI： 10.1038/bmt.2009.261

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  16 in total

Review 1.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Mini Kamboj; Nina Cohen; Yao-Ting Huang; Marina Kerpelev; Ann Jakubowski; Kent A Sepkowitz; Genovefa A Papanicolaou; Susan K Seo
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-15       Impact factor: 5.742

3.  Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.

Authors:  Nandita Khera; Amy Emmert; Barry E Storer; Brenda M Sandmaier; Edwin P Alyea; Stephanie J Lee
Journal:  Oncologist       Date:  2014-05-05

4.  Reduced mortality after allogeneic hematopoietic-cell transplantation.

Authors:  Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren A Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Journal:  N Engl J Med       Date:  2010-11-25       Impact factor: 91.245

5.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

6.  G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.

Authors:  Jinhua Ren; Qiaoxian Lin; Weimin Chen; Congmeng Lin; Yuxin Zhang; Cunrong Chen; Shaozhen Chen; Xiaohong Yuan; Ping Chen; Xiaofeng Luo; Yun Lin; Lvying Shen; Mengxian Guo; Qiuru Chen; Min Xiao; Yongquan Chen; Xueqiong Wu; Yanling Zeng; Zhizhe Chen; Xudong Ma; Jianda Hu; Ting Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

7.  Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.

Authors:  Michaël Schwarzinger; Luis Sagaon-Teyssier; Odile Cabaret; Stéphane Bretagne; Catherine Cordonnier
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Fungal spore concentrations in two haematopoietic stem cell transplantation (HSCT) units containing distinct air control systems.

Authors:  C P Brun; D Miron; L M R Silla; A C Pasqualotto
Journal:  Epidemiol Infect       Date:  2012-06-13       Impact factor: 4.434

9.  Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing.

Authors:  Michelle R Ananda-Rajah; David Martinez; Monica A Slavin; Lawrence Cavedon; Michael Dooley; Allen Cheng; Karin A Thursky
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

10.  Protective Isolation for Patients with Haematological Malignancies: A Pilot Study Investigating Patients' Distress and Use of Time.

Authors:  O Annibali; C Pensieri; V Tomarchio; V Biagioli; M Pennacchini; A Tendas; V Tambone; M C Tirindelli
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.